Literature DB >> 20096940

Lessons from the rotenone model of Parkinson's disease.

J Timothy Greenamyre, Jason R Cannon, Robert Drolet, Pier-Giorgio Mastroberardino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20096940      PMCID： PMC2846992          DOI： 10.1016/j.tips.2009.12.006

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  12 in total

1.  Variable effects of chronic subcutaneous administration of rotenone on striatal histology.

Authors:  Chunni Zhu; Patrick Vourc'h; Pierre-Olivier Fernagut; Sheila M Fleming; Sanja Lacan; Cheryl D Dicarlo; Ronald L Seaman; Marie-Françoise Chesselet
Journal:  J Comp Neurol       Date:  2004-10-25       Impact factor: 3.215

2.  Pesticide/environmental exposures and Parkinson's disease in East Texas.

Authors:  Amanpreet S Dhillon; G Lester Tarbutton; Jeffrey L Levin; George M Plotkin; Larry K Lowry; J Torey Nalbone; Sara Shepherd
Journal:  J Agromedicine       Date:  2008       Impact factor: 1.675

3.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease.

Authors:  R Betarbet; T B Sherer; G MacKenzie; M Garcia-Osuna; A V Panov; J T Greenamyre
Journal:  Nat Neurosci       Date:  2000-12       Impact factor: 24.884

4.  Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra.

Authors:  R J Ferrante; J B Schulz; N W Kowall; M F Beal
Journal:  Brain Res       Date:  1997-04-04       Impact factor: 3.252

5.  Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology.

Authors:  Robert E Drolet; Jason R Cannon; Laura Montero; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2009-07-10       Impact factor: 5.996

6.  A highly reproducible rotenone model of Parkinson's disease.

Authors:  Jason R Cannon; Victor Tapias; Hye Mee Na; Anthony S Honick; Robert E Drolet; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2009-05       Impact factor: 5.996

7.  A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease.

Authors:  Pier Giorgio Mastroberardino; Eric K Hoffman; Maxx P Horowitz; Ranjita Betarbet; Georgia Taylor; Dongmei Cheng; Hye Mee Na; Claire-Anne Gutekunst; Marla Gearing; John Q Trojanowski; Marjorie Anderson; Charleen T Chu; Junmin Peng; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2009-02-26       Impact factor: 5.996

Review 8.  Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?

Authors:  Francesca Cicchetti; Janelle Drouin-Ouellet; Robert E Gross
Journal:  Trends Pharmacol Sci       Date:  2009-09-02       Impact factor: 14.819

9.  Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.

Authors:  R E Heikkila; W J Nicklas; I Vyas; R C Duvoisin
Journal:  Neurosci Lett       Date:  1985-12-18       Impact factor: 3.046

10.  Pesticide exposure and risk of Parkinson's disease: a family-based case-control study.

Authors:  Dana B Hancock; Eden R Martin; Gregory M Mayhew; Jeffrey M Stajich; Rita Jewett; Mark A Stacy; Burton L Scott; Jeffery M Vance; William K Scott
Journal:  BMC Neurol       Date:  2008-03-28       Impact factor: 2.474
View more
  51 in total

1.  Bacopa monnieri extract offsets rotenone-induced cytotoxicity in dopaminergic cells and oxidative impairments in mice brain.

Authors:  George K Shinomol; Rajeswara Babu Mythri; M M Srinivas Bharath
Journal:  Cell Mol Neurobiol       Date:  2011-12-10       Impact factor: 5.046

2.  Acute exposure to the mitochondrial complex I toxin rotenone impairs synaptic long-term potentiation in rat hippocampal slices.

Authors:  Ryoichi Kimura; Lu-Yao Ma; Chen Wu; Dharshaun Turner; Jian-Xin Shen; Kevin Ellsworth; Makoto Wakui; Marwan Maalouf; Jie Wu
Journal:  CNS Neurosci Ther       Date:  2012-05-22       Impact factor: 5.243

3.  Inositol-related gene knockouts mimic lithium's effect on mitochondrial function.

Authors:  Lilach Toker; Yuly Bersudsky; Inbar Plaschkes; Vered Chalifa-Caspi; Gerard T Berry; Roberto Buccafusca; Dieder Moechars; R H Belmaker; Galila Agam
Journal:  Neuropsychopharmacology       Date:  2013-08-08       Impact factor: 7.853

Review 4.  Potential of animal models for advancing the understanding and treatment of pain in Parkinson's disease.

Authors:  Yazead Buhidma; Katarina Rukavina; Kallol Ray Chaudhuri; Susan Duty
Journal:  NPJ Parkinsons Dis       Date:  2020-01-06

5.  Mendelian randomization of serum urate and parkinson disease progression.

Authors:  Kelly Claire Simon; Shirley Eberly; Xiang Gao; David Oakes; Caroline M Tanner; Ira Shoulson; Stanley Fahn; Michael A Schwarzschild; Alberto Ascherio
Journal:  Ann Neurol       Date:  2014-10-03       Impact factor: 10.422

6.  LC/MS analysis of cardiolipins in substantia nigra and plasma of rotenone-treated rats: Implication for mitochondrial dysfunction in Parkinson's disease.

Authors:  Y Y Tyurina; A M Polimova; E Maciel; V A Tyurin; V I Kapralova; D E Winnica; A S Vikulina; M R M Domingues; J McCoy; L H Sanders; H Bayır; J T Greenamyre; V E Kagan
Journal:  Free Radic Res       Date:  2015-03-05

Review 7.  Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Authors:  J A Obeso; M Stamelou; C G Goetz; W Poewe; A E Lang; D Weintraub; D Burn; G M Halliday; E Bezard; S Przedborski; S Lehericy; D J Brooks; J C Rothwell; M Hallett; M R DeLong; C Marras; C M Tanner; G W Ross; J W Langston; C Klein; V Bonifati; J Jankovic; A M Lozano; G Deuschl; H Bergman; E Tolosa; M Rodriguez-Violante; S Fahn; R B Postuma; D Berg; K Marek; D G Standaert; D J Surmeier; C W Olanow; J H Kordower; P Calabresi; A H V Schapira; A J Stoessl
Journal:  Mov Disord       Date:  2017-09       Impact factor: 10.338

8.  Editor's Highlight: Nlrp3 Is Required for Inflammatory Changes and Nigral Cell Loss Resulting From Chronic Intragastric Rotenone Exposure in Mice.

Authors:  Eileen M Martinez; Alison L Young; Yash R Patankar; Brent L Berwin; Li Wang; Katharine M von Herrmann; Jaclyn M Weier; Matthew C Havrda
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

9.  Rotenone-induced energy stress decompensated in ventral mesocerebrum is associated with Parkinsonism progression in rats.

Authors:  Qunhua Bai; Junlin He; Yong Tang; Shibo Wang; Jingfu Qiu; Yang Wang; Chao Yu
Journal:  Exp Ther Med       Date:  2016-05-18       Impact factor: 2.447

10.  The effects and mechanism of estrogen on rats with Parkinson's disease in different age groups.

Authors:  Xue-Zhong Li; Chen-Yan Sui; Qiang Chen; Yuan-Su Zhuang; Hong Zhang; Xiao-Ping Zhou
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.